You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: September 25, 2023

Heparin sodium - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for heparin sodium and what is the scope of patent protection?

Heparin sodium is the generic ingredient in thirty-eight branded drugs marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, Solopak, Abraxis Pharm, Akorn, B Braun Medical Inc, Be Pharms, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Dr Reddys, Fresenius Kabi Usa, Gland, Hikma, Hospira Inc, Lilly, Mylan Labs Ltd, Nanjing King-friend, Organon Usa Inc, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Watson Labs Inc, Baxter Hlthcare, Mcgaw, B Braun, Pharma Serve Ny, and 3M, and is included in eighty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-nine drug master file entries for heparin sodium. Twenty-one suppliers are listed for this compound.

Summary for heparin sodium

US Patents:	0
Tradenames:	38
Applicants:	34
NDAs:	86
Drug Master File Entries:	49
Finished Product Suppliers / Packagers:	21
Clinical Trials:	98
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for heparin sodium
What excipients (inactive ingredients) are in heparin sodium?	heparin sodium excipients list
DailyMed Link:	heparin sodium at DailyMed

See drug prices for heparin sodium

Recent Clinical Trials for heparin sodium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Prevail Infoworks, Inc	Phase 2
Vaneltix Pharma, Inc.	Phase 2
The First Affiliated Hospital with Nanjing Medical University	N/A

See all heparin sodium clinical trials

Pharmacology for heparin sodium

Drug Class	Anti-coagulant Unfractionated Heparin

Anatomical Therapeutic Chemical (ATC) Classes for heparin sodium

US Patents and Regulatory Information for heparin sodium

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sandoz	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	201002-001	Jun 8, 2011	AP	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Gland	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	205323-002	Nov 18, 2019	AP	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Hospira	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	040095-001	Jul 26, 1996		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Hospira	HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45%	heparin sodium	INJECTABLE;INJECTION	018911-002	Jan 30, 1985		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Pfizer	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	201370-001	Jul 21, 2011		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Hikma	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	017007-004	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.